Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.260
-0.130 (-3.83%)
Jun 27, 2025, 1:49 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 87.56 million as of June 27, 2025. Its market cap has decreased by -65.49% in one year.
Market Cap
87.56M
Enterprise Value
105.99M
Revenue
44.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.26
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 87.56M, a decrease of -86.90%. That is a compound annual growth rate of -37.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 91.05M | 96.12% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.71B |
| Nordhealth AS | 2.78B |
| Photocure ASA | 1.39B |
| Vistin Pharma ASA | 1.11B |
| Omda AS | 1.07B |
| Gentian Diagnostics ASA | 934.59M |
| Thor Medical ASA | 863.74M |
| ArcticZymes Technologies ASA | 824.80M |